NJ ACTS Pilot Program Deadline–Letter of Intent Deadline: May 6, 2022 (required)(midnight)
via REDCap link: https://redcap.rwjms.rutgers.edu/surveys/?s=LJYKKM3J9A or https://redcap.link/nc0eena5
Read more about the NJ ACTS Pilots Program
One of the major objectives of NJ ACTS is to successfully translate biomedical discoveries to clinical applications by promoting creative and innovative science, and by providing pilot support for hypothesis generation and testing and building teams to address questions in translational science.
The NJ ACTS Pilot Program offers pilot grants to foster collaborative research among faculty in three institutions: Princeton University, New Jersey Institute of Technology (NJIT) and Rutgers University. We expect that the NJ ACTS Pilot Program will increase collaborative research and provide a path to sustainable, extramurally-funded, independent research across the alliance.
NJ ACTS will commit up to $640,000 this year. The program is funded through the generous support of the NIH CTSA Award, the New Jersey Health Foundation (NJHF), and each of the academic partners.
The leaders of the Pilot Program will host a webinar to explain the categories of funding, proposal requirements, regulatory requirements and NIH/NCATS approval processes, and to answer questions from participants.